Zymeworks (ZYME) Stock: Why The Price Rose 12.44% Today

By Amit Chowdhry ● May 2, 2022
  • The stock price of Zymeworks Inc (NYSE: ZYME) increased by 12.44% today. This is why.

The stock price of Zymeworks Inc (NYSE: ZYME) – a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics – increased by 12.44% today. Investors are responding positively to an unsolicited non-binding proposal from All Blue Falcons FZE (ABF) and its affiliates to purchase the company for $10.50 per share in cash at a deal value of $773 million.

Zymeworks also announced that management will participate in an upcoming investor conference.

H.C. Wainwright Global Investment Conference:

Zymeworks will participate virtually in one-on-one meetings on May 24th – 26th and a corporate presentation will be available virtually on May 24th at 7 a.m. ET.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.